The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Impact of individual comorbidities on post-transplant outcomes for elderly patients with non-Hodgkin lymphoma (NHL).
 
Andrew Ip
No Relationships to Disclose
 
Jeffrey M. Switchenko
No Relationships to Disclose
 
Michael Graiser
No Relationships to Disclose
 
Jean Louise Koff
No Relationships to Disclose
 
Vikas Anand Gupta
No Relationships to Disclose
 
Mary Jo Lechowicz
No Relationships to Disclose
 
Ajay K. Nooka
Consulting or Advisory Role - Novartis; Onyx
 
Jonathan L. Kaufman
Honoraria - Janssen
Consulting or Advisory Role - Abbvie; Janssen; Pharmacyclics; Roche; Takeda
Research Funding - Celgene (Inst); Merck (Inst); Novartis (Inst)
 
Sagar Lonial
Consulting or Advisory Role - Amgen; Bristol-Myers Squibb; Celgene; GlaxoSmithKline; Janssen Oncology; Millennium; Novartis; Onyx
 
Edmund K. Waller
Stock and Other Ownership Interests - Cambium Medical Technologies; Cerus; Chimerix
Honoraria - Novartis
Consulting or Advisory Role - Amgen; Cambium Medical Technologies; Celldex; Kalytera Therapeutics; Novartis
Research Funding - Amgen; Celldex; Novartis; Pharmacyclics
Patents, Royalties, Other Intellectual Property - CAMBIUM MEDICAL TECHNOLOGIES
 
Amelia A. Langston
Honoraria - Pfizer
Consulting or Advisory Role - Astellas Pharma
Research Funding - Astellas Pharma; Chimerix; Gilead Sciences; Incyte; Merck
Travel, Accommodations, Expenses - Astellas Pharma
 
Zaid S. Al-Kadhimi
No Relationships to Disclose
 
Vamsi Kota
No Relationships to Disclose
 
William G. Blum
No Relationships to Disclose
 
Rebecca B. Klisovic
No Relationships to Disclose
 
Kristie A. Blum
No Relationships to Disclose
 
Craig C. Hofmeister
Consulting or Advisory Role - Celgene; Thrasos Therapeutics
Research Funding - Arno Therapeutics; Bristol-Myers Squibb; Celgene; Janssen Oncology; Karyopharm Therapeutics; Takeda
Travel, Accommodations, Expenses - Amgen
 
Pamela Blair Allen
No Relationships to Disclose
 
Christopher Flowers
Consulting or Advisory Role - Abbvie; AstraZeneca; Bayer; BeiGene; Celgene; Denovo Biopharma; Gilead Sciences; Karyopharm Therapeutics; OptumRx; Pharmacyclics/Janssen; Seagen; Spectrum Pharmaceuticals
Research Funding - Abbvie (Inst); Acerta Pharma (Inst); BeiGene (Inst); Celgene (Inst); Genentech/Roche (Inst); Gilead Sciences (Inst); Immune Design (Inst); Infinity Pharmaceuticals (Inst); Janssen Oncology (Inst); Onyx (Inst); Pharmacyclics (Inst); TG Therapeutics (Inst)
Travel, Accommodations, Expenses - Celgene; Genentech/Roche; Gilead Sciences
 
Jonathon Brett Cohen
Consulting or Advisory Role - Abbvie; Celgene; Infinity Pharmaceuticals; Millennium; Novartis; Pharmacyclics; Seagen
Research Funding - Bristol-Myers Squibb; Janssen; Novartis; Takeda